Which PET tracer blurs less? study aims to sharpen prostate cancer detection

NCT ID NCT06604442

First seen Oct 01, 2025 · Last updated May 05, 2026 · Updated 32 times

Summary

This study involved 55 men whose prostate cancer returned after surgery, with very low PSA levels. Researchers compared two different radioactive tracers (piflufolastat and flotufolastat) used in PET scans to see which one caused less radioactivity in the bladder, potentially making it easier to spot cancer. The goal is to improve imaging accuracy for men with early signs of recurrence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • Endeavor Health- Glenbrook Hospital

    Glenview, Illinois, 60026, United States

  • Mayo Clinic

    Phoenix, Arizona, 85054, United States

  • Mayo Clinic

    Jacksonville, Florida, 32224, United States

  • Montefiore Medical Center

    The Bronx, New York, 10461, United States

  • Tower Urology

    Los Angeles, California, 90048, United States

  • Urology San Antonio

    San Antonio, Texas, 78229, United States

  • XCancer Omaha/Urology Cancer Center

    Omaha, Nebraska, 68130, United States

Conditions

Explore the condition pages connected to this study.